Le Lézard
Classified in: Health
Subject: MRR

Trauma Fixation Devices Market revenue to cross USD 9.2 Bn by 2027: Global Market Insights Inc.


- Major trauma fixation devices market players include Acumed LLC, Depuy Synthes (Johnson & Johnson), Integra LifeSciences, Smith & Nephew, Stryker Corporation, Zimmer Biomet Holdings Inc, Conmed Corporation, Bioretec Ltd., and B. Braun Melsungen AG.

SELBYVILLE, Del., Jan. 18, 2022 /PRNewswire/ -- The trauma fixation devices market size is anticipated to record a valuation of USD 9.2 billion by 2027, according to the most recent study by Global Market Insights Inc. Surge in the adoption rate of technologically advanced trauma fixation products coupled with growing geriatric population pool is augmenting the market growth during the forecast timeframe.

Trauma Fixation Devices Market

Geriatric population is more prone to hip fractures due to falls, thereby boost the trauma fixation devices market expansion. Additionally, increasing prevalence of degenerative bone disorders such as osteoporosis and arthritis with increasing age will further foster the market progression during the forecast timeframe. However, side effects such as rash and allergic reactions associated with trauma care procedures are hindering the acceptance rate of market. Also, the lack of skilled professionals to operate complex devices will hamper the market value.

Request for a sample of this research report @  https://www.gminsights.com/request-sample/detail/3745

Internal fixators segment captured USD 4 billion in 2020 owing to a rise in demand for such products attributed to its extensive features such as flexibility, cost-effectiveness, durability, stability and better bone fixation quality. These fixators provide the necessary support to the bone and results in rapid recovery from the medical condition. In addition, internal fixators enhance the bone healing process.

Stainless steel segment dominated more than 50% of the trauma fixation devices market share in 2020. Stainless steel is known for its high strength and good ductility. Thus, stainless steel is commonly used in fracture fixation devices and/or temporary implants. Moreover, patients and healthcare practitioners in developing countries largely prefer usage of stainless-steel credited to its cost-effectiveness, biocompatibility, and tensile properties, thus, contributing to the segment growth. Furthermore, stainless steel has superior or equal biochemical properties as compared to titanium metal. Stainless steel is significantly stiffer than bone thus, durable enough to allow the healing, thereby fueling its usage.

Upper extremities segment in the trauma fixation devices market is projected to witness 5.3% growth rate through 2027 led by the increase in incidence of sports-related injuries and orthopedic diseases among the population. A rise in number of baby boomers that are prone to injuries and bone diseases will drive the segment expansion in the coming years.

Many surgery patients are turning to ambulatory surgery centers for routine and minor procedures that does not require an overnight stay. Ambulatory surgery centers are cost effective and more convenient in nature than having surgery in hospital operating room. Additionally, these centers provide freedom in scheduling, opportunity to recover at home and financial savings to the patients, thereby stimulating the segment progression. Furthermore, growing incidence of road accidents will further augment the industry growth.

Asia Pacific trauma fixation devices market is poised to expand at more than 7.1% CAGR till 2027 owing to the increasing bone degenerative diseases among the population. Growing awareness among the population about various internal trauma fixation devices and rise in healthcare expenditure will further influence the industry expansion. Additionally, an increasing demand for minimally invasive procedures among the population will further accelerate the industry progression.

Request for customization of this research report @ 

https://www.gminsights.com/roc/3745 

A few notable companies operating in the market are Acumed LLC, Depuy Synthes (Johnson & Johnson), Integra LifeSciences, Smith & Nephew, Stryker Corporation, Zimmer Biomet Holdings Inc, Conmed Corporation, Bioretec Ltd., and B. Braun Melsungen AG. Industry players are focusing on various strategies such as acquisitions, business expansion, and novel product or service launches to consolidate their market presence.

Table of Contents (ToC) of the report:

Chapter 3 Trauma Fixation Devices Market Insights

3.1  Industry segmentation

3.2  Industry landscape, 2016 - 2027

3.3  Industry impact forces

3.3.1  Growth drivers

3.3.2  Industry pitfalls & challenges

3.4  Growth potential analysis

3.4.1  By product

3.4.2  By material

3.4.3  By site

3.4.4  By end-use

3.5  Regulatory landscape

3.6  Porter's analysis

3.7  Competitive landscape, 2020

3.7.1  Company market share analysis, 2020

3.8  PESTEL analysis

Browse Complete Table of Contents (ToC) @

https://www.gminsights.com/toc/detail/trauma-fixation-devices-market 

About Global Market Insights Inc.

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected] 

Photo: https://mma.prnewswire.com/media/1728397/Trauma_Fixation_Devices_Market.jpg
Logo: https://mma.prnewswire.com/media/661916/GMI.jpg

 

GMI Logo

 


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: